Authors: McBride, NC Cavenagh, JD Ward, MC Grant, I Schey, S Gray, A Hughes, A Mills, MJ Cervi, P Newland, AC Kelsey, SM

Citation: Nc. Mcbride et al., Liposomal daunorubicin (daunoxome) in combination with cyclophosphamide, vincristine and prednisolone (COPA) as salvage therapy in poor-prognosis non-Hodgkins lymphoma, LEUK LYMPH, 42(1-2), 2001, pp. 89-98

Authors: Visani, G Milligan, D Leoni, F Chang, J Kelsey, S Marcus, R Powles, R Schey, S Covelli, A Isidori, A Litchman, M Piccaluga, PP Mayer, H Malagola, M Pfister, C

Citation: G. Visani et al., Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia, LEUKEMIA, 15(5), 2001, pp. 764-771

Authors: Jackson, G Taylor, P Smith, GM Marcus, R Smith, A Chu, P Littlewood, TJ Duncombe, A Hutchinson, M Mehta, AB Johnson, SA Carey, P Mackie, MJ Ganly, PS Turner, GE Deane, M Schey, S Brookes, J Tollerfield, SM Wilson, MP

Citation: G. Jackson et al., A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation, BR J HAEM, 112(1), 2001, pp. 127-137

Authors: Ferguson, JSJ Summerhayes, M Masters, S Schey, S Smith, IE

Citation: Jsj. Ferguson et al., New treatments for advanced cancer: an approach to prioritization, BR J CANC, 83(10), 2000, pp. 1268-1273

Authors: Kottaridis, PD Milligan, DW Chopra, R Chakraverty, RK Chakrabarti, S Robinson, S Peggs, K Verfuerth, S Pettengell, R Marsh, JCW Schey, S Mahendra, P Morgan, GJ Hale, G Waldmann, H de Elvira, MCR Williams, CD Devereux, S Linch, DC Goldstone, AH Mackinnon, S

Citation: Pd. Kottaridis et al., In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation, BLOOD, 96(7), 2000, pp. 2419-2425

Authors: Wilson, HC Lunn, MPT Schey, S Hughes, RAC

Citation: Hc. Wilson et al., Successful treatment of IgM paraproteinaemic neuropathy with fludarabine, J NE NE PSY, 66(5), 1999, pp. 575-580